These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25017716)

  • 1. Establishment and characterization of a cisplatin‑resistant human osteosarcoma cell line.
    Han T; Zhu X; Wang J; Zhao H; Ma Q; Zhao J; Qiu X; Fan Q
    Oncol Rep; 2014 Sep; 32(3):1133-9. PubMed ID: 25017716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
    Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH
    Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of a paclitaxel‑resistant human esophageal carcinoma cell line.
    Wang C; Guo LB; Ma JY; Li YM; Liu HM
    Int J Oncol; 2013 Nov; 43(5):1607-17. PubMed ID: 24002547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of human osteosarcoma cells resistant to pyropheophorbide-α methyl ester-mediated photodynamic therapy.
    Tao Y; Ou Y; Yin H; Chen Y; Zhong S; Gao Y; Zhao Z; He B; Huang Q; Deng Q
    Int J Oncol; 2017 Nov; 51(5):1427-1438. PubMed ID: 29048645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [miR-365 inhibits proliferation and promotes apoptosis of SOSP9607 osteosarcoma cells].
    Gao J; Zhao P; Chen X; Wang W; Li Y; Xi W; Zhang W; Hu P; Wang T; Shan L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):44-8. PubMed ID: 26728377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
    Wang G; Rong J; Zhou Z; Duo J
    Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Establishment of a cisplatin-multidrug resistance cell line of human osteosarcoma].
    Zhang WT; Tu CQ; Liu Y; Li SF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):262-5. PubMed ID: 16608090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between chemotherapy resistance in osteosarcoma patients and PAK5 and Ezrin gene expression.
    Liu Q; Xu B; Zhou W
    Oncol Lett; 2018 Jan; 15(1):879-884. PubMed ID: 29391894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversion of P-glycoprotein-mediated multidrug resistance by diallyl trisulfide in a human osteosarcoma cell line.
    Wang Z; Xia Q; Cui J; Diao Y; Li J
    Oncol Rep; 2014 Jun; 31(6):2720-6. PubMed ID: 24788927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
    Xie XK; Yang DS; Ye ZM; Tao HM
    Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line.
    Yang JX; Luo Y; Qiu HM; Tang WX
    Saudi Med J; 2009 Jan; 30(1):35-40. PubMed ID: 19139770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer.
    Noma B; Sasaki T; Fujimoto Y; Serikawa M; Kobayashi K; Inoue M; Itsuki H; Kamigaki M; Minami T; Chayama K
    Int J Oncol; 2008 Dec; 33(6):1187-94. PubMed ID: 19020751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
    Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
    Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
    Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressing CHD1L reduces the proliferation and chemoresistance in osteosarcoma.
    Fan GT; Ling ZH; He ZW; Wu SJ; Zhou GX
    Biochem Biophys Res Commun; 2021 May; 554():214-221. PubMed ID: 33813077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 regulates the sensitivity to cisplatin in a human osteosarcoma cell line.
    Ziyan W; Yang L
    Ir J Med Sci; 2016 Feb; 185(1):85-91. PubMed ID: 25381586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells.
    Sun X; Wei Q; Cheng J; Bian Y; Tian C; Hu Y; Li H
    Hum Cell; 2017 Jul; 30(3):216-225. PubMed ID: 28326487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visfatin is involved in the cisplatin resistance of osteosarcoma cells via upregulation of Snail and Zeb1.
    Wang D; Qian G; Wang J; Wang T; Zhang L; Yang P; Lin F
    Cancer Biol Ther; 2019; 20(7):999-1006. PubMed ID: 30975015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FoxG1/BNIP3 axis promotes mitophagy and blunts cisplatin resistance in osteosarcoma.
    Pan B; Li Y; Han H; Zhang L; Hu X; Pan Y; Peng Z
    Cancer Sci; 2024 Aug; 115(8):2565-2577. PubMed ID: 38932521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.
    Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q
    Braz J Med Biol Res; 2017 Apr; 50(5):e6359. PubMed ID: 28443990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.